Feider Stephen sold BBNX
November 11, 2026 · Form 4 insider transaction
Feider Stephen sold 8,874 shares of Beta Bionics, Inc. at $17.21 per share, a transaction worth $152.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,874
Price
$17.21
Total value
$152.7K
InsiderFeider Stephen
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 11, 2026
Filing dateNovember 13, 2026
Shares owned after159,378
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.; The weighted average sale price for the transaction reported was $17.2054 and the range of prices were between $17.00 and $17.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.